Related references
Note: Only part of the references are listed.Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase
Jong Han Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
IL33/ST2 Axis in Diabetic Kidney Disease: A Literature Review
Alessandro Tonacci et al.
MEDICINA-LITHUANIA (2019)
Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy
Anna Michalczyk et al.
LIPIDS IN HEALTH AND DISEASE (2019)
Lysophosphatidic acid increases mesangial cell proliferation in models of diabetic nephropathy via Rac1/MAPK/KLF5 signaling
Donghee Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Mechanisms of Renal Fibrosis
Benjamin D. Humphreys
ANNUAL REVIEW OF PHYSIOLOGY, VOL 80 (2018)
New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors
Claire C. J. Dekkers et al.
CURRENT DIABETES REPORTS (2018)
Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury
Qi Cao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Advanced glycation end products in the pathogenesis of chronic kidney disease
Naila Rabbani et al.
KIDNEY INTERNATIONAL (2018)
Cellular death, reactive oxygen species (ROS) and diabetic complications
Caroline Maria Oliveira Volpe et al.
CELL DEATH & DISEASE (2018)
The Role of Advanced Glycation End Products in Diabetic Vascular Complications
Sang Youl Rhee et al.
DIABETES & METABOLISM JOURNAL (2018)
Intestinal Activation of pH-Sensing Receptor OGR1 [GPR68] Contributes to Fibrogenesis
Senta Hutter et al.
JOURNAL OF CROHNS & COLITIS (2018)
Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition
Volker Vallon et al.
DIABETOLOGIA (2017)
Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases
Yao Ye et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Urinary lysophopholipids are increased in diabetic patients with nephropathy
Jean-Sebastien Saulnier-Blache et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model
Ming-Zhi Zhang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice
Hui Ying Li et al.
KIDNEY INTERNATIONAL (2017)
Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor
Norihiko Sakai et al.
KIDNEY INTERNATIONAL (2017)
Autotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development
Silvia Anahi Valdes-Rives et al.
MEDIATORS OF INFLAMMATION (2017)
Role of the Wnt/β-catenin signaling pathway in inducing apoptosis and renal fibrosis in 5/6-nephrectomized rats
Xin Lin et al.
MOLECULAR MEDICINE REPORTS (2017)
Role of lysophosphatidic acid and its receptors in the kidney
Frank Park et al.
PHYSIOLOGICAL GENOMICS (2017)
Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy
Na Liu et al.
JOURNAL OF DIABETES RESEARCH (2017)
Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype - Role of Risk Factors and Epigenetics
Timothy D. Hewitson et al.
FRONTIERS IN PHARMACOLOGY (2017)
Matrix Metalloproteinases-7 and Kidney Fibrosis
Ben Ke et al.
FRONTIERS IN PHYSIOLOGY (2017)
Diabetic Kidney Disease Challenges, Progress, and Possibilities
Radica Z. Alicic et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Focal Segmental Glomerulosclerosis
Avi Z. Rosenberg et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Increased sphingosine 1-phosphate mediates inflammation and fibrosis in tubular injury in diabetic nephropathy
Dania Yaghobian et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2016)
Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy
Atsuko Tagawa et al.
DIABETES (2016)
Resveratrol attenuates renal injury and fibrosis by inhibiting transforming growth factor-beta pathway on matrix metalloproteinase 7
Zhou Xiao et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update
Niloy Bhattacharjee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Increased urinary lysophosphatidic acid in mouse with subtotal nephrectomy: potential involvement in chronic kidney disease
Koryun Mirzoyan et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2016)
Metabolomic Signatures of Chronic Kidney Disease of Diverse Etiologies in the Rats and Humans
Zhi-Hao Zhang et al.
JOURNAL OF PROTEOME RESEARCH (2016)
TGF-β signaling in the kidney: profibrotic and protective effects
Angara Sureshbabu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
Transforming growth factor-β1 and diabetic nephropathy
Albert S. Chang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
G-Protein-Coupled Lysophosphatidic Acid Receptors and Their Regulation of AKT Signaling
Anjum Riaz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Emerging role of podocyte autophagy in the progression of diabetic nephropathy
Mako Yasuda-Yamahara et al.
AUTOPHAGY (2015)
Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis
Olivia Lenoir et al.
AUTOPHAGY (2015)
Kruppel-like factor 5 incorporates into the β-catenin/TCF complex in response to LPA in colon cancer cells
Leilei Guo et al.
CELLULAR SIGNALLING (2015)
Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy
C. Hu et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Genetic and Functional Evidence Supports LPAR1 as a Susceptibility Gene for Hypertension
Ke Xu et al.
HYPERTENSION (2015)
The potential role of IL-33/ST2 signaling in fibrotic diseases
Qiaoyan Gao et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
JB Special Review-Recent Progress in Lipid Mediators Lysophosphatidic acid as a lipid mediator with multiple biological actions
Shizu Aikawa et al.
JOURNAL OF BIOCHEMISTRY (2015)
Autophagy in diabetic nephropathy
Yan Ding et al.
JOURNAL OF ENDOCRINOLOGY (2015)
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Kerstin Nowotny et al.
BIOMOLECULES (2015)
Markers of and Risk Factors for the Development and Progression of Diabetic Kidney Disease
Richard J. MacIsaac et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor
Sho Ishizawa et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2014)
Thematic Review Series: Lysophospholipids and their Receptors LPA receptor signaling: pharmacology, physiology, and pathophysiology
Yun C. Yung et al.
JOURNAL OF LIPID RESEARCH (2014)
Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles
Kerri J. Grove et al.
JOURNAL OF LIPID RESEARCH (2014)
The role of the kidneys in glucose homeostasis in type 2 diabetes: Clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors
John P. H. Wilding
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Unlocking the biology of RAGE in diabetic microvascular complications
Michaele B. Manigrasso et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Wnt/β-catenin signaling and kidney fibrosis
Roderick J. Tan et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2014)
Definition and Classification of Kidney Diseases
Andrew S. Levey et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
High glucose induces autophagy in podocytes
Tean Ma et al.
EXPERIMENTAL CELL RESEARCH (2013)
Development of lysophosphatidic acid pathway modulators as therapies for fibrosis
David C. Budd et al.
FUTURE MEDICINAL CHEMISTRY (2013)
The next generation of RAGE modulators: implications for soluble RAGE therapies in vascular inflammation
Marion A. Hofmann Bowman et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Obesity-Mediated Autophagy Insufficiency Exacerbates Proteinuria-induced Tubulointerstitial Lesions
Kosuke Yamahara et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
AKT2 is essential to maintain podocyte viability and function during chronic kidney disease
Guillaume Canaud et al.
NATURE MEDICINE (2013)
Unlike Two Peas in a Pod: Lipid Phosphate Phosphatases and Phosphatidate Phosphatases
Bernard P. C. Kok et al.
CHEMICAL REVIEWS (2012)
Characterization of Interleukin-33 and Soluble ST2 in Serum and Their Association with Disease Severity in Patients with Chronic Kidney Disease
Yu-Shi Bao et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling
Vivek Rai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site
Andres Nieto-Posadas et al.
NATURE CHEMICAL BIOLOGY (2012)
Correction: Berberine Reduces Fibronectin Expression by Suppressing the S1P-S1P2 Receptor Pathway in Experimental Diabetic Nephropathy Models
Kaipeng Huang et al.
PLoS One (2012)
The origin of interstitial myofibroblasts in chronic kidney disease
Ivica Grgic et al.
PEDIATRIC NEPHROLOGY (2012)
Tubulointerstitial injury and the progression of chronic kidney disease
Kavita S. Hodgkins et al.
PEDIATRIC NEPHROLOGY (2012)
VEGF and Podocytes in Diabetic Nephropathy
Alda Tufro et al.
SEMINARS IN NEPHROLOGY (2012)
EGF and angiotensin II modulate lysophosphatidic acid LPA1 receptor function and phosphorylation state
Christian C. Colin-Santana et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2011)
Altered Spatiotemporal Expression of Collagen Types I, III, IV, and VI in Lpar3-Deficient Peri-Implantation Mouse Uterus
Honglu Diao et al.
BIOLOGY OF REPRODUCTION (2011)
LPA Receptors: Subtypes and Biological Actions
Ji Woong Choi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
GPR35 is a novel lysophosphatidic acid receptor
Saori Oka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Autotaxin-an LPA producing enzyme with diverse functions
Keita Nakanaga et al.
JOURNAL OF BIOCHEMISTRY (2010)
TGF-β1 Protects against Mesangial Cell Apoptosis via Induction of Autophagy
Yan Ding et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Mechanistic connection between inflammation and fibrosis
Soo Bong Lee et al.
KIDNEY INTERNATIONAL (2010)
Identification and Characterization of a Novel Lysophosphatidic Acid Receptor, p2y5/LPA6
Keisuke Yanagida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Lipid phosphate phosphatases and signaling
David N. Brindley et al.
JOURNAL OF LIPID RESEARCH (2009)
Poor Glycemic Control in Diabetes and the Risk of Incident Chronic Kidney Disease Even in the Absence of Albuminuria and Retinopathy Atherosclerosis Risk in Communities (ARIC) Study
Lori D. Bash et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Identification of the orphan GPCR, P2Y10 receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor
Masanori Murakami et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Lysophosphatidic acid and renal fibrosis
Jean-Philippe Pradere et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
Two pathways for lysophosphatidic acid production
Junken Aoki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
Glycerolipid Metabolism and Signaling in Health and Disease
Marc Prentki et al.
ENDOCRINE REVIEWS (2008)
Diabetic nephropathy: Mechanisms of renal disease progression
Yashpal S. Kanwar et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth
Sandra M. Pasternack et al.
NATURE GENETICS (2008)
Mechanisms of Disease: the hypoxic tubular hypothesis of diabetic nephropathy
Dhruv K. Singh et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2008)
The role and characterization of phospholipase A1 in mediating lysophosphatidylcholine synthesis in Trypanosoma brucei
Gregory S. Richmond et al.
BIOCHEMICAL JOURNAL (2007)
LPA4/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing Gs-, Gq/Gi-mediated calcium signaling and G12/13-mediated Rho activation
Chang-Wook Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Homo- and hetero-dimerization of LPA/S1P receptors, OGR1 and GPR4
Alexander Zaslavsky et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2006)
GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5
Chang-Wook Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Mechanisms of tubulointerstitial fibrosis
M Iwano et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2004)
Mechanisms of lysophosphatidic acid production
J Aoki
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
Lysophospholipids in development: Miles apart and edging in
JD Saba
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family
K Noguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Identification of an intracellular receptor for lysophosphatidic acid (LPA):: LPA is a transcellular PPARγ agonist
TM McIntyre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A novel phospholipase A1 with sequence homology to a mammalian Sec23p-interacting protein, p125
K Nakajima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Functional comparisons of the lysophosphatidic acid receptors, LPA1NVZG-1/EDG-2, LPA2/EDG-4, and LPA3/EDG-7 in neuronal cell lines using a retrovirus expression system
I Ishii et al.
MOLECULAR PHARMACOLOGY (2000)
Share Paper
